Available 24/7 via chat
Available 24/7 via chat

In pharmaceutical and biotechnology manufacturing, maintaining strict air quality control is essential to protecting product integrity, patient safety, and regulatory compliance.
Even microscopic airborne particles can compromise sterile production processes, contaminate biological products, or cause costly batch failures.
Air filtration systems play a critical role in controlling particulate contamination, microbial risks, and airborne chemical compounds within pharmaceutical and biotechnology facilities.
Properly designed filtration systems ensure stable cleanroom environments, support regulatory compliance, and safeguard both product quality and worker safety.
Clean-Link provides engineered air filtration solutions designed for pharmaceutical cleanrooms, biotechnology production facilities, and research laboratories.
Pharmaceutical and biotech facilities operate under some of the most stringent environmental control requirements of any industry. Maintaining controlled air quality presents several challenges.
Airborne contaminants such as dust particles, bacteria, viruses, and volatile organic compounds (VOCs) can easily enter production environments if filtration systems are inadequate.
Even submicron particles can cause cross-contamination between production lines or compromise sterile processes. In biotechnology environments, airborne microbial contamination can affect sensitive biological materials and experimental results.
Effective air filtration is essential to capture airborne particles and maintain a controlled environment throughout the facility.

Pharmaceutical facilities must comply with strict regulatory frameworks that define acceptable contamination levels and cleanroom performance requirements.
Common standards include:
ISO 14644 cleanroom classification standards
EU GMP Annex 1 sterile manufacturing guidelines
FDA cGMP requirements for pharmaceutical production
Maintaining compliance requires reliable air filtration systems capable of delivering consistent air quality performance over extended operating periods.
Products such as vaccines, biologics, injectables, and cell therapy materials are extremely sensitive to airborne contamination.
Sterile production areas must maintain carefully controlled environments with stable airflow patterns and minimal particulate presence. Any breach in air quality control can compromise product sterility and lead to production shutdowns or product recalls.
High-efficiency air filtration systems are therefore essential components of pharmaceutical facility design.
Air filtration systems are fundamental to maintaining contamination-controlled environments across pharmaceutical manufacturing and biotechnology research operations.

Cleanrooms rely on high-efficiency filtration systems to control airborne particle concentrations and maintain regulatory classification levels.
HEPA and ULPA filters capture microscopic particles and microorganisms, preventing contaminants from entering critical production areas.
These filtration systems support cleanroom classifications defined by ISO 14644, helping maintain controlled production environments.
Advanced filtration systems remove a wide range of airborne contaminants, including dust particles, bacteria, fungal spores, and viruses.
HEPA filters are designed to capture at least 99.97 percent of particles at the most penetrating particle size (MPPS), typically between 0.1 and 0.3 microns. ULPA filters provide even higher filtration efficiency for the most demanding applications.
In addition to particulate control, pharmaceutical facilities must also manage humidity, temperature, and airborne chemical contaminants.
Activated carbon filtration can remove volatile organic compounds and odors generated during pharmaceutical processes, protecting both workers and sensitive materials.
Effective air filtration systems are required in multiple areas within pharmaceutical and biotechnology facilities.
Cleanrooms require high-efficiency filtration to maintain controlled airborne particle concentrations.
Filtration prevents airborne microbes from entering sterile manufacturing environments.
Filtration protects experiments from environmental contamination.
Biotech manufacturing environments require strict microbial contamination control.
Pharmaceutical HVAC systems typically use multi-stage filtration to ensure reliable contamination control.

Stage 1 – Pre-filtration
Removes large airborne particles and protects downstream filters.
Stage 2 – Fine filtration
Captures smaller particles and improves overall filtration efficiency.
Stage 3 – HEPA terminal filtration
Installed at the cleanroom ceiling or air terminal units to maintain final air cleanliness.
This staged filtration design improves system efficiency, reduces filter replacement frequency, and ensures long-term cleanroom stability.
Clean-Link provides a comprehensive range of filtration solutions designed for pharmaceutical and biotechnology environments.

Available filtration products include:
Pre-filters compliant with ISO 16890
Fine filtration solutions for HVAC systems
HEPA filters compliant with EN 1822
High-efficiency ceiling filters for cleanrooms
Activated carbon filters for VOC removal
All filtration products are manufactured under an ISO 9001 certified quality management system to ensure consistent performance and reliability.

Effective filtration prevents airborne contamination that may compromise pharmaceutical products.
Reliable filtration systems help facilities meet GMP and ISO cleanroom standards.
Removing airborne pathogens and chemical contaminants improves workplace safety.
Optimized filtration systems reduce maintenance costs and improve HVAC performance.
Pharmaceutical cleanrooms typically use multi-stage air filtration systems consisting of pre-filters, fine filters, and terminal HEPA filters.
Pre-filters capture larger airborne particles, while HEPA filters provide final-stage filtration to maintain cleanroom air quality according to ISO 14644 standards.
HEPA filters are essential in pharmaceutical manufacturing because they remove at least 99.97 percent of airborne particles at the most penetrating particle size (MPPS).
This level of filtration helps prevent contamination in sterile production environments and supports compliance with GMP cleanroom requirements.
Air filtration systems in pharmaceutical facilities are typically designed to comply with standards such as ISO 14644 for cleanroom classification, EU GMP Annex 1 for sterile manufacturing, and FDA cGMP regulations.
These standards define acceptable particle limits and air cleanliness levels.
HEPA filter replacement schedules depend on pressure drop levels, operating hours, and contamination loads.
In most pharmaceutical cleanrooms, HEPA filters are monitored through differential pressure measurements and integrity testing to determine the appropriate replacement interval.
HEPA filters remove at least 99.97 percent of particles at the most penetrating particle size, while ULPA filters provide even higher filtration efficiency, typically removing 99.999 percent or more of airborne particles.
ULPA filters are used in applications requiring extremely high cleanliness levels.
Selecting the right filtration system for pharmaceutical and biotechnology facilities requires expertise in cleanroom airflow design, regulatory compliance, and contamination control.
Clean-Link provides technical consultation and customized filtration solutions designed for pharmaceutical manufacturing environments.
Contact us today for personalized advice and assistance tailored to your specific requirements.
Tell us your application, filter size, efficiency requirement, or replacement target. Our team can help you select the right solution, optimize system performance, and provide factory-direct pricing.
Technical selection support
Custom sizes and OEM options
Factory-direct pricing
Bulk order and project support



$150.00 away from free shipping!